Expression profiling in APP23 mouse brain: inhibition of Aβ amyloidosis and inflammation in response to LXR agonist treatment-5

<p><b>Copyright information:</b></p><p>Taken from "Expression profiling in APP23 mouse brain: inhibition of Aβ amyloidosis and inflammation in response to LXR agonist treatment"</p><p>http://www.molecularneurodegeneration.com/content/2/1/20</p><p>Molecular Neurodegeneration 2007;2():20-20.</p><p>Published online 22 Oct 2007</p><p>PMCID:PMC2214725.</p><p></p>d : Rat microglia were treated with 5 μM T0 and GW and then LPS (B) or Aβas in Fig. 5; IL-6 secretion was measured by ELISA. The values (means ± SEM) indicate the concentration of the cytokines in mg/ml and are normalized to the total cellular protein (TP). LXR treatments are compared to LPS or Aβalone by two-tailed Student's test.*, p < 0.05, **, p < 0.01, and ***, p < 0.001